Concepedia

Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)

Winnie Yeo, Michael Boyer, Hyun Cheol Chung, Simon Yew Kuang Ong, Robert Lim, Benny Zee, Brigette Ma, K.C. Lam, Frankie Mo, Enders K. Ng,

Cancer Chemotherapy and Pharmacology · 2006 · 18 citations · 27 references

DOIFull text

Open access

Concepts

References

27

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Cancer statistics, 1998

Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1998 · 2.4K citations · Full text

, , +17

One-Sample Multiple Testing Procedure for Phase II Clinical Trials

Thomas R. Fleming · Biometrics · 1982 · 997 citations

, , +13

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Andrew Webb, David Cunningham, J.H. Scarffe et al. · Journal of Clinical Oncology · 1997 · 873 citations

, , +15

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

Seppo Pyrhönen, Tapio Kuitunen, Paul Nyandoto et al. · British Journal of Cancer · 1995 · 797 citations · Full text

, , +11